Elective lymph node dissection in patients with melanoma: Systematic review and meta-analysis of randomized controlled trials

Archives of Surgery

Volumn 137, Issue 4, 2002, Pages 458-461

  Lens, Marko B ^a   Dawes, Martin ^a   Goodacre, Tim ^a   Newton Bishop, Julia A ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; ELECTIVE SURGERY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL;

HUMANS; LYMPH NODE EXCISION; MELANOMA; RANDOMIZED CONTROLLED TRIALS; SKIN NEOPLASMS; SURGICAL PROCEDURES, ELECTIVE; SURVIVAL RATE;

EID: 0036086633     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Current therapy for melanoma
2. Cancer statistics
3. Melanotic cancerous disease
4. Principles of sentinel lymph node identification: Background and clinical implications
5. Elective lymph node dissection in stage I malignant melanoma: A meta-analysis
6. Cost analysis of sentinel lymph node biopsy as an alternative to elective lymph node dissection in patients with malignant melanoma
7. Elective lymph node dissection for melanoma: Two perspectives
8. Elective lymph node dissection in the management of malignant melanoma
9. Theoretical and empirical arguments in relation to elective lymph node dissection for melanoma
10. Judging the therapeutic value of lymph node dissections for melanoma
11. Technical details of intraoperative lymphatic mapping for early stage melanoma
12. The argument against sentinel node biopsy for malignant melanoma
13. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities
14. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial
15. Efficacy of an elective regional lymph node dissection of 1-4 mm thick melanomas for patients 60 years of age or younger
16. Lymphadenectomy in the management of stage I malignant melanoma: A prospective randomised study
17. Inefficacy of immediate node dissection in stage I melanoma of the limbs
18. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm): Intergroup Melanoma Surgical Trial
19. Elective lymph node dissection in primary malignant melanoma
20. Role of elective lymph node dissection in melanoma